Preliminary reports suggest conolidine may inhibit particular ion channels, reducing neuronal excitability and limiting agony indicators. This mechanism is particularly related in neuropathic discomfort, wherever abnormal signaling results in persistent pain. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral t